|
Re: What an incredible...
|
2
|
Resverlogix Corp.
|
Dec 22, 2019 03:26PM
|
|
Re: Apabetalone May Repress Toxic Gene in Rare Muscular Dystrophy (FSHD)
|
2
|
Resverlogix Corp.
|
Sep 10, 2018 11:14AM
|
|
Re: Shrinking MACE event rate
|
2
|
Resverlogix Corp.
|
Jan 20, 2019 04:22PM
|
|
Re: Don't See Us Listed but thought it might interest some
|
2
|
Resverlogix Corp.
|
Mar 11, 2021 09:26AM
|
|
Re: Another Exempt Distribution - 2021-04-15
|
2
|
Resverlogix Corp.
|
Apr 18, 2021 08:26AM
|
|
Re: Dr. Mark Day interview with Proactive Investors at BIO CEO
|
2
|
BIOASIS TECHNOLOGIES INC
|
Feb 13, 2019 02:24PM
|
|
Re: Can someone explain the Biogen situation to me....
|
2
|
Resverlogix Corp.
|
Oct 28, 2019 12:28PM
|
|
Re: Good luck!
|
2
|
Resverlogix Corp.
|
Sep 19, 2021 03:33PM
|
|
Re: What impact would a PR like this have?
|
2
|
Resverlogix Corp.
|
Jan 29, 2019 01:37PM
|
|
Re: Can Hepalink afford US rights?
|
2
|
Resverlogix Corp.
|
Feb 04, 2019 04:04PM
|
|
Re: Warrants conversion!
|
2
|
Resverlogix Corp.
|
Nov 27, 2019 11:21AM
|
|
Warrants back in favour?
|
2
|
Resverlogix Corp.
|
Feb 10, 2022 10:30AM
|
|
Re: Biogen/Eisai Scrap Aducanumab
|
2
|
Resverlogix Corp.
|
Mar 21, 2019 03:37PM
|
|
Re: Bioasis Acquires Phase 2 Ready Rare Orphan EGF Assets
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jun 21, 2022 09:45AM
|
|
Re: Book closes.....
|
2
|
Resverlogix Corp.
|
Jun 05, 2019 08:36AM
|
|
Re: Diabetes, dementia, and ABL
|
2
|
Resverlogix Corp.
|
Dec 22, 2019 04:30PM
|
|
Re: Options
|
2
|
Resverlogix Corp.
|
Oct 23, 2019 07:17AM
|
|
Re: Report of exempt distribution
|
2
|
Resverlogix Corp.
|
Jul 01, 2020 06:35PM
|
|
Re: Little confused, any insight would be great
|
2
|
Resverlogix Corp.
|
Mar 05, 2024 05:04AM
|
|
Re: News out - Dosing of First Cancer Patient with a Combination of ZEN-3694 + Bristol Myers Squibb’s Immune Checkpoint Inhibitor OPDIV
|
2
|
Zenith Epigenetics
|
Feb 25, 2022 07:54AM
|
